ScienceDex / Researcher record
Colonna, Marco
- Washington University in St. Louis · Pathology (NIH department code)
From the FY2013 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Sustained Excellence
- Program Leader
- R01 Holder
- Long-Funded
- Mentor
NIH Funding · FY2013
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2006 | $799,684 | 3 | #6,927 |
| 2007 | $1,100,886 | 4 | #5,806 |
| 2008 | $516,515 | 2 | #13,643 |
| 2009 | $288,800 | 1 | #28,351 |
| 2010 | $650,712 | 2 | #13,597 |
| 2011 | $714,856 | 2 | #10,400 |
| 2012 | $714,932 | 2 | #10,418 |
| 2013 | $1,372,602 | 6 | #4,314 |
| 2014 | $1,468,938 | 7 | #4,251 |
| 2015 | $2,984,023 | 4 | #1,486 |
| 2016 | $1,269,778 | 2 | #5,114 |
| 2017 | $2,734,490 | 3 | #1,583 |
| 2018 | $4,224,733 | 5 | #747 |
| 2019 | $5,772,799 | 5 | #506 |
| 2020 | $2,505,566 | 3 | #594 |
| 2021 | $4,158,980 | 6 | #981 |
| 2022 | $3,092,785 | 7 | #1,660 |
| 2023 | $2,652,436 | 6 | #2,296 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20063 records
- FY20074 records
- FY20082 records
- FY20091 record
- FY20102 records
- FY20112 records
- FY20122 records
- FY2013 · selected6 records
- FY20147 records
- FY20154 records
- FY20162 records
- FY20173 records
- FY20185 records
- FY20195 records
- FY20203 records
- FY20216 records
- FY20227 records
- FY20236 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
FY2013 award records by amount
NIH award records listing Colonna, Marco as a PI. Multi-PI records show the full award amount for context.
- 5U01AI095542-03U01Contact PIMucosal Immune Defense Mechanisms of the Urinary BladderWashington University in St. Louis · Pathology (NIH department code)$425.2Kaward amount
- 5R01DE021255-04R01Contact PITHE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITYWashington University in St. Louis · Pathology (NIH department code)$346.7Kaward amount
- 5T32DK007296-34T32Contact PICell Biologic approaches to Diabetes ResearchWashington University in St. Louis · Pathology (NIH department code)$191.1Kaward amount
- 1R21AI105728-01R21Contact PITHE ROLE OF IL-34 IN THE BIOLOGY OF LANGERHANS CELLSWashington University in St. Louis · Pathology (NIH department code)$190Kaward amount
- 1R21CA167192-01A1R21Contact PICONTROLLING NK CELL ANTI-CANCER ACTIVITY: THE ROLE OF NUTRIENTS AND SUPPLEMENTSWashington University in St. Louis · Pathology (NIH department code)$165.3Kaward amount
- 3T32DK007296-34S1T32Contact PICell Biologic approaches to Diabetes ResearchWashington University in St. Louis · Pathology (NIH department code)$54.2Kaward amount
Award organization
Organizations that administered FY2013 awards listing Colonna, Marco as a PI.
FY2013 award administered by Washington University in St. Louis (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardWashington University in St. Louis
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #6927
- 2007$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2012R01 Grant Holder
- 2013$5M Cumulative Funding
- 2013Entered Top 25% NationallyRanked #4314
- 2015$10M Cumulative Funding
- 2015Entered Top 10% NationallyRanked #1486
- 2015Program/Center Grant Leader
- 2018Entered Top 5% NationallyRanked #747
- 2020$25M Cumulative Funding